Krista McKerracher

Executive

NervGen Pharma Corp.

Insider activity · 24 months0 buys11 salesCumulative net flow

Dec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 7 salesMar 26 · 0 buys · 2 salesApr 26 · 0 buys · 2 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (11 ops.)

€204k

Latest filing published 09 Sept 2026 for NervGen Pharma Corp., €79k.

Filing timeline

BuySale

Krista McKerracher

Insider track record

Disclosed buys

Disclosed sells

Signal history

Krista McKerracher: trading record in brief

Krista McKerracher is a declared insider of NervGen Pharma Corp., with filings sourced from SEDI. Over a trading history stretching from 9 September 2021 to 4 September 2026, the count stands at 18 filings.

The open-market record consists of 11 sales worth €204k, with no purchase. The rest of the record consists of 3 option exercises. Since January 2026: no purchases and 11 sales on the market.

The newest entry dates from 9 September 2026: an option exercise of €79k, in NervGen Pharma Corp. Filings reach the SEDI feed a median of 4 days after the trade. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.

Companies and markets linked to Krista McKerracher

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

NervGen Pharma Corp. (CA)

Declarations18 total

◇
Krista McKerracher
4 - Director of IssuerExecutives4 Sept 2026NervGen Pharma Corp.
127,600 CAD0SEDI
55,000 shares@ CA$2.3244.9% of flowOptionsTSXSEDI:4775677
◇
Krista McKerracher
4 - Director of IssuerExecutives28 Aug 2026NervGen Pharma Corp.
37,017 CAD12SEDI
17,627 shares@ CA$2.100.0060% mcap13.7% of flowCommon SharesTSXSEDI:4770513
●
Krista McKerracher
4 - Director of IssuerExecutives9 Sept 2021NervGen Pharma Corp.
0SEDI
Common SharesTSXSEDI:4770511
◇
Krista McKerracher
4 - Director of IssuerExecutives28 Aug 2026NervGen Pharma Corp.
105,000 CAD0SEDI
50,000 shares@ CA$2.1038.9% of flowOptionsTSXSEDI:4770507
▼
Krista McKerracher
4 - Director of IssuerExecutives2 Apr 2026NervGen Pharma Corp.
21,150 CAD12SEDI
5,000 shares@ CA$4.235.6% of flowCommon SharesTSXSEDI:4700954
▼
Krista McKerracher
4 - Director of IssuerExecutives8 Apr 2026NervGen Pharma Corp.
41,914 CAD12SEDI
10,000 shares@ CA$4.191411.0% of flowCommon SharesTSXSEDI:4700949
▼
Krista McKerracher
4 - Director of IssuerExecutives9 Mar 2026NervGen Pharma Corp.
19,924 CAD12SEDI
5,000 shares@ CA$3.98486.4% of flowCommon SharesTSXSEDI:4679876
▼
Krista McKerracher
4 - Director of IssuerExecutives26 Feb 2026NervGen Pharma Corp.
20,514 CAD12SEDI
5,000 shares@ CA$4.10286.4% of flowCommon SharesTSXSEDI:4668320
▼
Krista McKerracher
4 - Director of IssuerExecutives2 Mar 2026NervGen Pharma Corp.
38,517 CAD12SEDI
10,000 shares@ CA$3.851712.1% of flowCommon SharesTSXSEDI:4668311
▼
Krista McKerracher
4 - Director of IssuerExecutives26 Feb 2026NervGen Pharma Corp.
20,639 CAD12SEDI
5,000 shares@ CA$4.12786.5% of flowCommon SharesTSXSEDI:4668318
▼
Krista McKerracher
4 - Director of IssuerExecutives18 Feb 2026NervGen Pharma Corp.
41,312 CAD12SEDI
10,000 shares@ CA$4.131210.8% of flowCommon SharesTSXSEDI:4663822
▼
Krista McKerracher
4 - Director of IssuerExecutives20 Feb 2026NervGen Pharma Corp.
42,914 CAD12SEDI
9,980 shares@ CA$4.3011.3% of flowCommon SharesTSXSEDI:4663827
▼
Krista McKerracher
4 - Director of IssuerExecutives19 Feb 2026NervGen Pharma Corp.
86 CAD11SEDI
20 shares@ CA$4.300.0% of flowCommon SharesTSXSEDI:4663826
▼
Krista McKerracher
4 - Director of IssuerExecutives19 Feb 2026NervGen Pharma Corp.
41,773 CAD12SEDI
10,000 shares@ CA$4.177310.9% of flowCommon SharesTSXSEDI:4663825
▼
Krista McKerracher
4 - Director of IssuerExecutives12 Feb 2026NervGen Pharma Corp.
39,958 CAD12SEDI
10,000 shares@ CA$3.995810.5% of flowCommon SharesTSXSEDI:4661007
●
Krista McKerracher
4 - Director of IssuerExecutives9 Sept 2021NervGen Pharma Corp.
0SEDI
Common SharesTSXSEDI:4289603
●
Krista McKerracher
4 - Director of IssuerExecutives28 Mar 2024NervGen Pharma Corp.
13,531 CAD12SEDI
5,758 shares@ CA$2.355.2% of flowCommon SharesTSXSEDI:4289604
●
Krista McKerracher
4 - Director of IssuerExecutives9 Sept 2021NervGen Pharma Corp.
0SEDI
Common SharesTSXSEDI:4240252

18 of 18 declarations

Krista McKerracher

Insider track record

Krista McKerracher: trading record in brief

Companies and markets linked to Krista McKerracher

Related entities